Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595‐nm pulsed dye laser combined with the 1927‐nm fractional low‐powered diode laser

Melasma presents a significant challenge to laser surgeons. Aggressive treatments often result in rebound melasma or post‐inflammatory pigmentary alteration. Recent reports suggest melasma pathogenesis may have a vascular component. Spectrocolorimetry can detect subtle or sub‐clinical telangiectatic erythema within melasma lesions. For certain patients identified by spectrocolorimetry, effective melasma treatment may include vascular‐targeted therapy together with pigment‐specific treatment modalities. Such combined therapies may reduce the likelihood of melasma recurrence.